BioCryst Pharmaceuticals BCRX Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's common stock, shares, outstanding?
- BioCryst Pharmaceuticals (BCRX) reported common stock, shares, outstanding of $254.01M in Q1 2026.
- How has BioCryst Pharmaceuticals's common stock, shares, outstanding changed year-over-year?
- BioCryst Pharmaceuticals's common stock, shares, outstanding increased by 21.4% year-over-year, from $209.21M to $254.01M.
- What is the long-term trend for BioCryst Pharmaceuticals's common stock, shares, outstanding?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's common stock, shares, outstanding has grown at a 4.3% compound annual growth rate (CAGR), from $187.91M to $213.06M.